FMC vs. CTVA: Which Stock Is the Better Value Option?
Investors interested in Agriculture - Operations stocks are likely familiar with FMC (FMC) and Corteva, Inc. (CTVA). But which of these two companies is the best option for those looking for undervalued stocks?
FMC (FMC) Reports Q2 Earnings: What Key Metrics Have to Say
Although the revenue and EPS for FMC (FMC) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
FMC's Earnings Surpass Estimates in Q2 on Higher Volumes
FMC posts better-than-expected Q2 results as higher volumes offset price declines.
FMC (FMC) Q2 Earnings and Revenues Beat Estimates
FMC (FMC) came out with quarterly earnings of $0.69 per share, beating the Zacks Consensus Estimate of $0.59 per share. This compares to earnings of $0.63 per share a year ago.
These 2 Consumer Staples Stocks Could Beat Earnings: Why They Should Be on Your Radar
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
FMC (FMC) Expected to Beat Earnings Estimates: Should You Buy?
FMC (FMC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
FMC or CTVA: Which Is the Better Value Stock Right Now?
Investors interested in stocks from the Agriculture - Operations sector have probably already heard of FMC (FMC) and Corteva, Inc. (CTVA). But which of these two companies is the best option for those looking for undervalued stocks?
Will FMC (FMC) Beat Estimates Again in Its Next Earnings Report?
FMC (FMC) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
FMC's Tremisia Fungicide Debuts in EMEA Region After Approvals
FMC launches Tremisia fungicide in Ukraine, bringing fluindapyr tech to EMEA growers battling major crop diseases.
Hold On To FMC Corporation (Rating Downgrade)
We assess FMC Corporation as a Hold to moderate buy, downgrading from a previous buy opportunity due to weak growth, momentum, and financial potential. FMC's strengths are its innovation, R&D focus, and attractive 5.4% dividend yield, but revenue and profit have declined for several years. FMC valuation is fair around $50 per share, but insider and hedge fund selling, high debt, and weak near-term growth limit upside.
FMC and Corteva Partner to Expand Access to Fluindapyr Fungicide
FMC teams up with Corteva to expand fluindapyr fungicide access, targeting key U.S. corn and soybean markets.
Why Is FMC (FMC) Up 2.3% Since Last Earnings Report?
FMC (FMC) reported earnings 30 days ago. What's next for the stock?
